This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Longitude Prize on Antimicrobial Resistance (AMR)
What is the Longitude Prize on Antimicrobial Resistance (AMR) ?
The Longitude Prize is looking for a team of researchers to invent an affordable, accurate, fast and easy-to-use test for bacterial infections that will allow health professionals worldwide to administer the right antibiotics at the right time. £8 million will be awarded to the winner, to help solve the global problem of antibiotic resistance.
Why are we doing this?
On average, antibiotics add 20 years to each person’s life. The development of antibiotics has been vital to our survival, yet the rise of antimicrobial resistance is threatening to make them ineffective in the future. Point-of-care test kits will allow more targeted use of antibiotics, and an overall reduction in misdiagnosis and prescription. They will form a vital part of the toolkit for stewardship of antibiotics in the future. This will ensure that the antibiotics we have now will be effective for longer and we can continue to control infections during routine and major procedures.
What are we doing?
Currently we are working with and supporting more than 50 competing teams of innovators around the world. We are supporting them with collaboration opportunities, preparing them for market-readiness, profiling, and connecting them with new funding opportunities. The prize is open to new entrants at any point.
The Longitude Prize on Antimicrobial Resistance (AMR) is delivered in partnership with
The Longitude Prize on Antimicrobial Resistance (AMR)
Where are we now?
The deadline to submit an entry to win the £8 million prize is 30 September 2022.
The deadline was extended in 2020 to ensure that the competing teams have enough time to complete development of their rapid point-of-care diagnostic tests that can help slow the development of antimicrobial resistance (AMR).
The Longitude Prize Sprint programme, consisting of free, technical workshops with industry experts, plus a package of bespoke 1-to-1 expert support sessions for competitors, was also launched in 2020.
Today there are more than 50 registered competitors: new teams are still welcome to join the competition. The challenge can be won at any time.
The Judges
Along with the Longitude Prize’s Advisory Panel the Longitude Committee is responsible for on-going prize consultation and will, ultimately, judge and decide which entry should win.
-
![Andrew Cohen]()
Andrew Cohen
Head of BBC Science Unit
-
![Andrew Dunnett]()
Andrew Dunnett
Director of the Vodafone Foundation
-
![Penny Wilson]()
Dr Penny Wilson
Senior Specialist, AMR, Vaccines and Global Health
-
![Dr Roger Highfield]()
Dr Roger Highfield
Director of External Affairs, Science Museum
-
![Dr Sir Patrick Vallance]()
Dr Sir Patrick Vallance
Government Chief Scientific Adviser
-
![Tim Jinks]()
Dr Tim Jinks
Head of Drug Resistant Infections Priority Program, Wellcome Trust